Incidental Detection of Spondyloarthritis on FDG-PET/CT Performed for Unintentional Weight Loss

Clicks: 1
ID: 320558
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #10 of 43 articles by views in Modern Rheumatology Case Reports

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract 18F-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) is frequently used to evaluate malignancy. However, FDG uptake is not cancer-specific and may also be seen in inflammatory rheumatic diseases. Recognition of musculoskeletal uptake patterns can prevent misdiagnosis and prompt targeted evaluation. A 60-year-old woman developed unintentional weight loss. Malignant lymphoma was suspected based on elevated serum C-reactive protein, axillary lymphadenopathy, and elevated soluble interleukin-2 receptor. FDG-PET/CT demonstrated prominent uptake in the sternoclavicular joints, both shoulders, wrists, and the sacroiliac joints. She presented with long-standing inflammatory back pain, and examination showed reduced lumbar mobility. Pelvic radiography revealed grade 3 sacroiliitis in the right sacroiliac joint, and cervical radiography showed bulky asymmetric paravertebral ossification changes. MRI demonstrated STIR hyperintensity in the sacroiliac joints. Because FDG uptake was also observed in the sternoclavicular joints, synovitis-acne-pustulosis-hyperostosis-osteitis syndrome was considered; however, no characteristic skin lesions were present. She was diagnosed with spondyloarthritis (SpA). Ixekizumab was initiated, resulting in rapid clinical improvement. This case illustrates that FDG-PET/CT performed for suspected malignancy can incidentally reveal a characteristic musculoskeletal uptake pattern of SpA. That prompt recognition of this pattern enables timely initiation of effective IL-17A inhibition, leading to rapid improvement in systemic inflammation and clinical symptoms.
Reference Key
openalex_W7167889648 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Haruki Matsumoto, Hiroki Nibu, Shuhei Yoshida, Tomoyuki Asano, Shuzo Sato, Yasuhiro Shimojima
Journal Modern Rheumatology Case Reports
Year 2026
DOI
10.1093/mrcr/rxag073
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.